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The surface protein internalin A (InlA) contributes to the invasion of human intestinal epithelial cells
by Listeria monocytogenes. Screening of L. monocytogenes strains isolated from human clinical cases (n �
46), foods (n � 118), and healthy animals (n � 58) in the United States revealed mutations in inlA leading
to premature stop codons (PMSCs) in L. monocytogenes ribotypes DUP-1052A and DUP-16635A (PMSC
mutation type 1), DUP-1025A and DUP-1031A (PMSC mutation type 2), and DUP-1046B and DUP-1062A
(PMSC mutation type 3). While all DUP-1046B, DUP-1062A, DUP-16635A, and DUP-1031A isolates (n �
76) contained inlA PMSCs, ribotypes DUP-1052A and DUP-1025A (n � 72) contained isolates with and
without inlA PMSCs. Western immunoblotting showed that all three inlA PMSCs result in the production
of truncated and secreted InlA. Searches of the Pathogen Tracker database, which contains subtype and
source information for more than 5,000 L. monocytogenes isolates, revealed that the six ribotypes shown to
contain isolates with inlA PMSCs were overall more commonly isolated from foods than from human
listeriosis cases. L. monocytogenes strains carrying inlA PMSCs also showed signiﬁcantly (P � 0.0004)
reduced invasion of Caco-2 cells compared to isolates with homologous 3� inlA sequences without PMSCs.
Invasion assays with an isogenic PMSC mutant further supported the observation that inlA PMSCs lead
to reduced invasion of Caco-2 cells. Our data show that speciﬁc L. monocytogenes subtypes which are
common among U.S. food isolates but rare among human listeriosis isolates carry inlA mutations that are
associated with, and possibly at least partially responsible for, an attenuated invasion phenotype.
Listeria monocytogenes is a facultative intracellular food-borne
pathogen that may cause encephalitis, meningitis, septicemia, or
spontaneous late-term abortions in susceptible individuals (34).
Although the incidence of listeriosis is low, listeriosis has a high
case fatality rate (20 to 30%), which makes this disease a consid
erable public health concern (19). While L. monocytogenes can
be classiﬁed into 13 different serotypes, only a few speciﬁc
serotypes (4b, 1/2a, and 1/2b) are responsible for the majority
(approximately 90%) of human listeriosis cases (18). Molecu
lar subtyping studies have shown that L. monocytogenes iso
lates can be grouped into three genetic lineages (reviewed in
reference 41). While different studies have suggested that
L. monocytogenes genetic lineages and subtypes differ in their
epidemiological associations with speciﬁc hosts and nonhost
environments (6, 12, 18, 22, 26, 39), very limited information is
available on underlying genetic mechanisms that may be re
sponsible for virulence differences among L. monocytogenes
subtypes. A better understanding of genetic differences and
their relationship to virulence differences among L. monocyto
genes strains is critical to allow the development of accurate
science-based L. monocytogenes risk assessments.
Internalin (InlA), which is encoded by inlA, is an 800-amino
acid (aa) surface protein that facilitates the entry of L. mono

cytogenes into epithelial cells that express speciﬁc forms of
E-cadherin. InlA appears to contribute to the invasion of in
testinal epithelial cells by L. monocytogenes, an important ﬁrst
step in the pathogenesis of systemic listeriosis (17). While InlA
may also contribute to crossing of the placental barrier by
L. monocytogenes (16), a role for InlA in the pathogenesis of
listerial abortions could not be conﬁrmed in animal experi
ments using a guinea pig model (1). Interestingly, a series of
studies on L. monocytogenes strains isolated in France identi
ﬁed at least six distinct nonsense mutations in inlA upstream of
the region encoding the InlA membrane anchor (11, 13, 29,
31), resulting in the expression of a truncated form of InlA
which is secreted rather than anchored to the bacterial cell wall
(13). No studies have characterized the presence of L. mono
cytogenes isolates with nonsense mutations in inlA from coun
tries other than France.
A previous study (24) by our group on the molecular phy
logeny and evolution of 120 L. monocytogenes isolates obtained
from human and animal clinical cases and foods in the United
States revealed three unique mutations in inlA leading to pre
mature stop codons (PMSCs), which appear to differ from
those previously described for L. monocytogenes isolates from
France. The current study was thus conducted to (i) identify
additional mutations leading to PMSCs in inlA by using a
larger collection of L. monocytogenes isolates collected in the
United States, (ii) deﬁne the prevalence of L. monocytogenes
isolates harboring inlA PMSC mutations among human, ani

TABLE 1. Description of L. monocytogenes isolate sets used for this study
Isolate
set no.

1
2

3

4

5

6

Description

Purpose and use of isolate set a

36 food isolates representing all 36 EcoRI ribotypes found among
food isolates collected in the United States, as described by
Gray et al. (6)
58 isolates representing L. monocytogenes EcoRI ribotypes
commonly detected in feces from healthy ruminants, selected
from a previously described collection of 108 L. monocytogenes
fecal isolates from healthy ruminants (25)
62 ribotype DUP-1062A isolates, representing all available
DUP-1062A isolates from human listeriosis infections (n � 12),
and 50 DUP-1062A food isolates selected from the 151
DUP-1062A food isolates described by Gray et al. (6) to
represent a variety of different ready-to-eat foods
54 ribotype DUP-1052A isolates, representing all 30 DUP-1052A
isolates from human listeriosis infections that were not
previously characterized and 24 food isolates selected from the
58 DUP-1052A food isolates described by Gray et al. (6) to
represent a variety of different ready-to-eat foods
Eight ribotype DUP-1025A isolates, representing all four
DUP-1025A isolates from human listeriosis infections that were
not previously characterized and selected food isolates (n � 4)

Isolates were screened by sequencing an �1,600-bp 3� fragment
of inlA to identify premature stop codon mutations associated
with food isolates
Isolates were screened by sequencing an �1,600-bp 3� fragment
of inlA to identify premature stop codon mutations associated
with isolates from healthy cattle

All DUP-16635A isolates from foods (n � 4) that were not
previously characterized

Isolates were screened by PCR-RFLP to identify the presence
of premature stop codon mutation type 3; all DUP-1062A
isolates characterized by serotyping (n � 11) were serotype
1/2a
Isolates were screened by sequencing an �800-bp 3� fragment
of inlA to identify the presence of premature stop codon
mutation type 1; all DUP-1052A isolates characterized by
serotyping (n � 10) were serotype 1/2b
Isolates were screened by sequencing an �800-bp 3� fragment
of inlA to identify the presence of premature stop codon
mutation type 2; all DUP-1025A isolates characterized by
serotyping (n � 9) were serotype 1/2b
Isolates were screened by sequencing an �800-bp 3� fragment
of inlA to identify the presence of premature stop codon
mutation type 1; all DUP-16635A isolates (n � 5) were
serotype 1/2b

a
The number of isolates characterized by serotyping included 8 DUP-1052A, 2 DUP-1025A, 1 DUP-1031A, 3 DUP-1062A, and 2 DUP-1046B isolates serotyped
by Nightingale et al. (24) as well as 24 isolates that were not previously reported.

mal, and food-source populations in the United States, and
(iii) determine the invasion phenotypes of L. monocytogenes
strains with and without inlA PMSCs.
MATERIALS AND METHODS
Bacterial strains. Six L. monocytogenes isolate sets (Table 1) were assembled
from our culture collection of �5,000 L. monocytogenes isolates to screen for the
presence of inlA PMSCs among L. monocytogenes strains isolated from different
source populations in the United States. All isolates included in these six sets are
described in detail in Supplemental Table 1 (http://www.foodscience.cornell.edu
/wiedmann/Nightingale%20Supplementary2.txt). inlA sequencing data for these
isolates have not been reported previously.
inlA sequencing. L. monocytogenes isolates representing molecular subtypes
commonly isolated from foods and fecal samples from healthy ruminants (isolate
sets 1 and 2; Table 1) were screened for the presence of PMSCs in inlA by ﬁrst
sequencing the 3� end of inlA (approximately 800 bp) and subsequently sequenc
ing an additional, approximately 800-bp fragment (5� of the initial 3� 800-bp
region sequenced) if no PMSC mutations were detected in the initial 3� frag
ment. To speciﬁcally screen for the presence of PMSC mutation types 1 and 2,
which were previously mapped to the 3� end of inlA (24), DNA sequencing of the
3� fragment of inlA (approximately 800 bp) was conducted. Primer sequences
used for PCR ampliﬁcation and/or DNA sequencing as well as PCR conditions
are detailed in Supplemental Tables 2 and 3 (http://www.foodscience.cornell.edu
/wiedmann/Nightingale%20Supplementary2.txt). PCR was performed using Taq
polymerase (Promega, Madison, WI) as described previously (24). PCR products
were also puriﬁed, quantiﬁed, and sequenced using forward and reverse PCR
primers as described previously (24). Nucleotide sequences were proofread and
aligned with Seqman and MegAlign (Lasergene software suite; DNAStar,
Madison, WI), respectively.
PCR-RFLP. Partial inlA DNA sequence data for four DUP-1062A and all
available DUP-1046B L. monocytogenes isolates from food samples previously
uncovered the presence of a speciﬁc PMSC mutation (PMSC mutation type 3) in
these isolates (24). A PCR-restriction fragment length polymorphism (PCR
RFLP) assay was developed to screen for the presence of this inlA PMSC
mutation in DUP-1062A isolates from human clinical cases and from foods
(Table 1). An analysis of inlA sequences with and without inlA PMSC mutation
type 3 identiﬁed RsaI as a restriction enzyme that differentiates sequences with

and without this mutation. PCR primers (Supplemental Table 2) were designed
to amplify a 180-bp fragment of inlA encompassing PMSC mutation type 3. RsaI
recognizes a sequence found in inlA sequences without PMSC mutation type 3,
so L. monocytogenes isolates with PMSC mutation type 3 were expected to show
a single 180-bp fragment after PCR-RFLP, while isolates without this mutation
were expected to yield two fragments (117 and 63 bp). PCR was performed as
described in Supplemental Table 3. PCR products were digested with RsaI (New
England Biolabs, Beverly, MA) for 1 h at 37°C and subsequently analyzed by
3.0% agarose gel electrophoresis. Isolates conﬁrmed by DNA sequencing to
carry or not carry PMSC mutation type 3 were used as positive controls.
Caco-2 invasion assays. Caco-2 invasion assays were performed essentially as
previously described (28). Brieﬂy, L. monocytogenes isolates were grown over
night at 30°C without shaking. Conﬂuent Caco-2 monolayers were inoculated
with 2 � 107 L. monocytogenes cells/well. Serial dilutions of the inoculum were
plated on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, MI)
plates. Inoculated Caco-2 monolayers were incubated for 30 min at 37°C, fol
lowed by three washes with phosphate-buffered saline and the addition of fresh
medium without antibiotics. Medium containing 150 �g/ml gentamicin was
added at 45 min postinoculation to kill extracellular bacteria. At 90 min post
inoculation, Caco-2 monolayers were washed three times with phosphate-buff
ered saline. Caco-2 cells were lysed by the addition of cold sterile distilled water
and vigorous pipetting. Intracellular L. monocytogenes cells were enumerated by
spread plating lysed Caco-2 cell suspensions on BHI agar plates. The invasion
efﬁciency was reported as the percentage of the inoculum recovered by the
enumeration of intracellular bacteria. A standard laboratory control strain
(10403S) and uninoculated BHI broth were included as controls in each invasion
assay. Three independent invasion assays were performed for each L. monocy
togenes strain tested (Table 2).
Generation of an isogenic inlA PMSC mutant. An isogenic mutant of labora
tory strain 10403S (2) carrying inlA PMSC mutation type 3 (located at codon 700
of the inlA open reading frame) was generated. Site-directed mutagenesis was
performed using SOE-PCR (splicing by overlap extension PCR) (10), using
primers (5� to 3�) Marq 147 (AACTGCAGCTGGGAATTTATTGACTGG),
Marq 149 (GTAAATTGAGCCTACAGCGTAATG), Marq 148 (CATTAC
GCTGTAGGCTCAATTTAC), and Marq 150 (GCGGTACCTTGCTTGATT
GGCGTTGGC). First, two fragments were ampliﬁed by PCR from strain
10403S, using primer pairs Marq 147/Marq 149 and Marq 148/Marq 150. Primers
Marq 148 and 149 are complementary and introduce inlA PMSC mutation type

TABLE 2. L. monocytogenes strains and isolates used for Western blot analysis and invasion assays
Strain (previous name)

Genotype or ribotype

10403S
FSL K4-006 (EJL12, HEL-202)
FSL K4-007 (HEL-137)
FSL K4-009
FSL W3-084 (HEL-399)
FSL F2-245a
FSL F2-563a
FSL F2-897b
FSL R2-074b
FSL F2-539 (EGD-e)c
FSL F2-515c

Wild type
10403S �inlA
10403S �inlB
10403S �inlAB
10403S inlA with stop codon at aa 700 (PMSC mutation type 3)
DUP-1052A, full-length inlA
DUP-1052A, PMSC mutation type 1
DUP-1025A, full-length inlA
DUP-1025A, PMSC mutation type 2
Full length inlA
DUP-1062A, PMSC mutation type 3

Source or reference

2
1
15
14
This
This
This
This
This
5
This

paper
paper
paper
paper
paper
paper

a

FSL F2-245 and FSL F2-563 have identical 3� inlA sequences, except for premature stop codon mutation type 1 in isolate FSL F2-563.
FSL F2-897 and FSL R2-074 have identical 3� inlA sequences, except for premature stop codon mutation type 2 in isolate FSL R2-074.
c
FSL F2-539 (EGD-e) and FSL F2-515 have identical 3� inlA sequences, except for premature stop codon mutation type 3 in isolate FSL F2-515.
b

3 (TAG) at codon 700. The PCR products were puriﬁed and combined in a
second PCR with primers Marq 147 and 150. The 1,098-bp product was digested
with PstI and KpnI and ligated into pKSV7. The mutated inlA allele was veriﬁed
by sequencing and recombined into the chromosome of L. monocytogenes 10403S
by allelic exchange as previously described (3).
Western blotting. Western immunoblot analysis of bacterial cell wall and
supernatant fractions for the presence of InlA was performed on L. monocytogenes grown in LB supplemented with 50 mM morpholinepropanesulfonic acid
(MOPS) adjusted to pH 7.3, 25 mM glucose-1-phosphate, and 0.2% activated
charcoal. Chloramphenicol was added (10 �g/ml) 10 min prior to the harvest.

Cell wall and supernatant fractions were prepared as previously described (36).
Equivalent amounts of culture (in optical density [OD] units) were loaded per
lane. Proteins were detected by Western immunoblotting using a mouse antiInlA antiserum provided by T. Potter (National Jewish Medical and Research
Center, Denver, CO) (15, 36).
Phylogenetic inference. A multiple sequence alignment of the 3� end of inlA
(706 nucleotides) was created in MegAlign using the inlA sequences for all
L. monocytogenes isolates (n � 160) sequenced for this study and sequences
containing PMSCs from our previous study (24). This alignment was used to
generate a data ﬁle for phylogenetic analyses containing a single representative

FIG. 1. Full-length InlA (A) and locations of premature stop codons in InlA previously identiﬁed by research groups in France (B, C, D, E,
H, and I) and reported here (F, G, and J). Full-length InlA represents the sequence for L. monocytogenes strain EGD-e. N, N-terminal end; S,
signal sequence; LRR, leucine-rich repeat; IR, intergenic repeat; MA, membrane anchor; C, C-terminal end. Numbers below the EGD-e InlA
sequence represent aa positions. Numbers at the right end for panels B to F represent the aa positions of the respective premature stop codons.

TABLE 3. Occurrence of premature inlA stop codons among six
EcoRI ribotypes found to contain these mutations

Mutation
type

Ribotype

a

DUP-1052A
DUP-16635Ab
DUP-1025Ac
DUP-1031Ad
DUP-1062Ae
DUP-1046B f

1
1
2
2
3
3

Incidence of premature inlA
stop codon (no. of isolates
with mutation [no. of isolates
screened]) among isolates
obtained from:
Humans

Food

Total

7 (35)
0 (0)
0 (5)
0 (0)
12 (12)
0 (0)

13 (27)
5 (5)
2 (6)
1 (1)
55 (55)
3 (3)

20 (62)
5 (5)
2 (11)
1 (1)
67 (67)
3 (3)

Prevalence (%)
of premature inlA
stop codon among
all isolates

32.3
100.0
18.2
100.0
100.0
100.0

a
Data represent 54 isolates from isolate set 4 (Table 1), one food isolate with
ribotype DUP-1052A from isolate set 1, and ﬁve human and two food isolates
from the work of Nightingale et al. (24).
b
Data represent four isolates from isolate set 6 (Table 1) and one food isolate
with ribotype DUP-16635A from isolate set 1.
c
Data represent eight isolates from isolate set 5 (Table 1), one food isolate
with ribotype DUP-1025A from isolate set 1, and one human and one food
isolate from the work of Nightingale et al. (24).
d
Data represent one food isolate with ribotype DUP-1031A from isolate set 1
(Table 1).
e
Data represent 62 isolates from isolate set 3 (Table 1), one food isolate with
ribotype DUP-1062A from isolate set 1, and four food isolates from the work of
Nightingale et al. (24).
f
Data represent one food isolate with ribotype DUP-1046B from isolate set 1
and two food isolates from the work of Nightingale et al. (24).

isolate for each inlA allele (n � 38), using DnaSP, version 3.99 (32). A maximum
likelihood phylogenetic tree was inferred using DNA substitution parameters
selected by MODELTEST (30) and PAUP* (37), as previously described (24).
Serotyping. Serotyping of L. monocytogenes was performed using the glass
agglutination method (7, 38) and commercial Listeria antiserum (Seiken Listeria
antiserum; Denka Seiken, Tokyo, Japan). Results were interpreted according to
the serotyping scheme of Seeliger and Hohne (35).
Statistical analysis. Chi-square tests were performed to describe the preva
lence of PMSCs in food and human clinical isolates and to describe the distri
bution of ribotypes that carry inlA PMSCs among isolates from foods and human
clinical listeriosis cases. Fisher’s exact test was used if expected values were below
5 for one or more cells. A nonparametric equivalent to the t test (Wilcoxon rank
sum test) was used to assess the difference in invasion efﬁciencies between the
two groups of L. monocytogenes strains studied (i.e., strains with and without
premature inlA stop codons). P values of �0.05 were considered statistically
signiﬁcant.
Nucleotide sequence accession numbers. A single sequence representing each
unique inlA allele (n � 38) identiﬁed in this study was deposited in GenBank
(accession no. DQ125375 to DQ125412). Accession no. DQ125408, DQ125406,
and DQ125387 represent inlA sequences containing PMSC mutation types 1, 2,
and 3, respectively. Sequences for all isolates characterized by partial inlA se
quencing in this study (n � 160) are available through Pathogen Tracker (www
.pathogentracker.net).

PMSC mutations 3� of the highly conserved leucine-rich repeat
(LRR) region of InlA are rare among fecal isolates from
healthy ruminants. Together with previous studies (11, 13, 29,
31), our results suggest that L. monocytogenes isolates with
PMSCs in inlA are distributed worldwide and may represent a
signiﬁcant virulence-attenuated subpopulation of L. monocy
togenes commonly isolated from foods. While the occurrence
of multiple distinct ecologically successful inlA PMSC muta
tions suggests positive selection for the loss of cell wall-an
chored InlA, the reservoir(s) of L. monocytogenes strains with
secreted InlA and the selective advantages associated with
these mutations remain to be established.
Multiple distinct inlA PMSCs are found in different L. mono
cytogenes EcoRI ribotypes that are commonly isolated from foods
and rarely cause human disease in the United States. A previous
study by our group (24) identiﬁed three unique inlA PMSC
mutations in four L. monocytogenes ribotypes (ribotypes DUP
1052A, DUP-1062A, DUP-1046B, and DUP-1031A). Ribo
types DUP-1062A and DUP-1052A were not only previously
shown to be the two most common L. monocytogenes ribotypes
among more than 30,000 food samples collected in the United
States (together representing 41.7% of 502 L. monocytogenes
food isolates [6]) but were also found to be signiﬁcantly more
common among food isolates than among human clinical iso
lates (6). We thus hypothesized that inlA PMSCs might be
associated with reduced human virulence among certain
L. monocytogenes subtypes found in the United States. Since
previous studies in France have also found multiple mutations
leading to PMSCs in the 3� region of inlA (11, 13, 29, 31), we
initially sequenced the 3� region of inlA (covering the region
where PMSCs were previously identiﬁed [11, 13, 24, 29, 31]) in
36 L. monocytogenes isolates (isolate set 1; Table 1) represent
ing all 36 ribotypes found among 502 previously collected U.S.
food isolates (6). This isolate set included ribotypes commonly
linked to human listeriosis cases (e.g., DUP-1038B, DUP
1042B, and DUP-1044A [6]). We identiﬁed two additional
ribotypes, DUP-1025A and DUP-16635A, which carry inlA
PMSCs. The inlA mutations identiﬁed here occurred in the

RESULTS AND DISCUSSION
While previous studies described inlA PMSCs among
L. monocytogenes strains isolated in France from human fecal
carriers and foods as well as, less commonly, from human
clinical cases (11, 13, 29, 31), we were not aware of any data on
the presence and distribution of inlA PMSCs in L. monocyto
genes isolates from countries other than France. Our data
reported here show that (i) multiple distinct inlA PMSC mu
tations are found in different L. monocytogenes EcoRI ribo
types, which overall are commonly isolated from foods and
rarely cause human disease in the United States; (ii) isolates
carrying inlA mutations resulting in PMSCs show attenuated
invasiveness in human intestinal epithelial cells; and (iii) inlA

FIG. 2. Western blot detection of InlA from broth-grown bacteria.
Strains tested included (i) the laboratory control strain 10403S, which
encodes full-length InlA (2,400 bp, 800 aa); (ii) an isogenic 10403S �inlA
mutant (HEL-202, FSL K4-006); (iii) an isogenic mutant with PMSC
mutation type 3 in a 10403S background (HEL-399, FSL W3-084); (iv) a
wild-type isolate with PMSC mutation type 1 (FSL F2-563); and (v) a
wild-type isolate with PMSC mutation type 2 (FSL R2-074). Proteins in
the cell wall (C) and in the supernatant (S) fraction were detected by
Western immunoblotting with a mouse anti-InlA antiserum.

FIG. 3. Phylogenetic tree depicting evolutionary relatedness of inlA alleles sequenced. The tree was constructed using a 706-bp 3� fragment of
inlA. Alleles representing premature stop codon mutation types 1, 2, and 3 are marked PMSC 1, 2, and 3, respectively. Genetic lineage I (as
determined by EcoRI ribotyping) isolates are shown in red, lineage II isolates are shown in green, and lineage III isolates are shown in blue. inlA
sequence data for lineage III isolates (n � 3), which have previously been shown to be distantly related to lineage I and II isolates (42), were used
as an outgroup to root the inlA maximum likelihood tree. Bootstrap conﬁdence measures above 50.0% for nodes in the inlA phylogram are shown
at the nodes they describe. The inlA sequences used to construct this tree are available from GenBank (accession no. DQ125375 to DQ125412).

same locations previously identiﬁed by our group (24) (Fig. 1).
inlA PMSCs among the isolates screened thus represent three
distinct mutation types (PMSC mutation types 1 through 3),
with each occurring in two ribotypes (Table 3). All three inlA
PMSC mutations observed here appear to be distinct from
those reported in previous studies that provided DNA se
quence data allowing us to map the speciﬁc mutations leading
to PMSCs (13, 29, 31) (Fig. 1). We could not establish whether
the mutations observed here were also distinct from those
leading to truncated InlA in food and human clinical isolates
collected in France (11), since these isolates were only char
acterized by Western blot analysis, which does not permit a
deﬁnitive identiﬁcation of speciﬁc mutations leading to PMSCs.
All three inlA PMSCs observed here were located within 100
aa of each other and were positioned 3� of the conserved LRR
region and 5� of the C-terminal LPXTG membrane-anchoring
motif (Fig. 1). The occurrence of inlA PMSCs in this region
was previously linked to the production of a truncated InlA
protein that is secreted rather than anchored to the cell wall

(11, 13). Western blot analysis conﬁrmed that the inlA PMSCs
reported here also result in the production of a truncated and
secreted InlA protein (Fig. 2).
Phylogenetic analyses showed that the inlA PMSCs reported
here represent three distinct evolutionary events (Fig. 3). The
clustering of the inlA sequences containing mutations leading
to PMSCs is also consistent with the lineage classiﬁcation of
the isolates carrying these mutations (Fig. 3). Speciﬁcally, inlA
alleles carrying PMSC mutation types 1 and 2 group with other
lineage I inlA sequences, and the PMSC mutation type 3 allele
groups with lineage II isolates (Fig. 3). The lineage classiﬁca
tion was also consistent with serotype classiﬁcation (Table 3).
Isolates with PMSC mutation types 1 and 2 were serotype 1/2b,
which is typical for lineage I strains (23), while isolates with
PMSC mutation type 3 were serotype 1/2a, which is typical for
lineage II strains (23). In a previous study (24), sequencing the
3� 800 bp of inlA failed to reveal any PMSC mutations among
36 lineage I L. monocytogenes isolates representing serotype
4b, a serotype associated with the majority of human listeriosis

TABLE 4. Frequency of L. monocytogenes ribotypes associated with premature inlA stop codons among isolates in the
Pathogen Tracker database
EcoRI ribotype

DUP-1052A
DUP-16635A
DUP-1025A
DUP-1031A
DUP-1062A
DUP-1046B
Total

Mutation
type

Lineagea

1
1
2
2
3
3

I
I
I
I
II
II

Serotype
(no.)b

1/2b (10)
1/2b (5)
1/2b (9)
1/2b (1)
1/2a (11)
1/2a (3)

No. (prevalence [%]) of isolates in Pathogen Tracker c obtained from:
Humans

d

35 (3.5)
0
5 (0.5)
0
12 (1.2)
0
1,009

Animalse

1 (0.08)
0
2 (0.15)
0
0
0
1,297

Foodsf

78 (5.0)
5 (0.3)
6 (0.4)
1 (0.06)
170 (10.9)*
3 (0.2)
1,562

Otherg

82 (6.8)
1 (0.1)
4 (0.3)
0
37 (3.1)
0
1,213

Total

196 (3.9)
6 (0.1)
17 (0.3)
1 (0.02)
219 (4.3)
3 (0.06)
5,081

a

Lineages were assigned based on the EcoRI ribotypes, as described by Wiedmann et al. (42).
b
Numbers reﬂect eight DUP-1052A, two DUP-1025A, one DUP-1031A, three DUP-1062A, and two DUP-1046B isolates serotyped by Nightingale et al. (24) as well
as serotypes for 24 isolates not previously reported.
c
Numbers represent isolates present in Pathogen Tracker on 1 August 2004; detailed source information on isolates can be obtained at www.pathogentracker.net.
Percentages represent the prevalence of isolates with a given ribotype among all isolates in a given category (e.g., humans).
d
The majority of human isolates (�90%) were from invasive listeriosis cases in North America.
e
Animal isolates included isolates from animals with invasive listeriosis as well as fecal isolates from animals without symptoms of listeriosis, the majority of which
(�95%) were from North America.
f
The majority of food isolates (�95%) were from North America. *, statistically signiﬁcantly (P � 0.0001) more common among food isolates than among human
isolates.
g
Other isolates included isolates from various environments, including food processing plants, as well as isolates of unknown origin.

cases (18). The majority (n � 40) of the ruminant fecal isolates
characterized in this study belonged to lineage II, which pre
dominantly includes serotypes 1/2a and 1/2c (23). Thus, the
lack of inlA premature stop codon mutations among animal
isolates does not appear to represent an overrepresentation of
isolates of serotype 4b, which is predominantly found among
lineage I isolates and not found in lineage II isolates. We also
recently identiﬁed a frameshift mutation in the 5� portion of
inlA, leading to a PMSC in the signal sequence of InlA (Fig. 1).
This frameshift mutation was observed in L. monocytogenes
isolates from foods that were characterized as ribotype DUP
1039C and serotype 1/2c (R. Orsi and M. Wiedmann, unpub
lished data). Interestingly, previous studies in France only
identiﬁed inlA PMSC mutations 3� of the LRR region of InlA
in serotype 1/2c and 1/2a isolates (11), further conﬁrming that
the inlA PMSCs observed here represent genetic events inde
pendent from those leading to the emergence of the inlA
PMSCs in France. The fact that at least nine independent
evolutionary events (Fig. 1) in both of the major L. monocy
togenes genetic lineages led to the generation of ecologically
successful inlA alleles carrying PMSC mutations suggests the
occurrence of positive selection and thus a distinct ecological
advantage for a loss of cell wall-anchored InlA.
To further understand the prevalence and distribution of
PMSC mutation types 1 through 3 among L. monocytogenes
isolates in the United States, we assembled additional larger
isolate sets (sets 3 through 6; Table 1) of human clinical iso
lates and food isolates representing four of the six ribotypes
found here to carry inlA PMSC mutations (all isolates repre
senting ribotypes DUP-1031A and DUP-1046B were charac
terized previously [24]). We screened these isolates using inlA
sequencing or a newly developed RsaI PCR-RFLP assay tar
geting the single nucleotide polymorphism (SNP) responsible
for PMSC mutation type 3, the most common mutation leading
to truncated and secreted InlA. All isolates representing ribo
types DUP-16635A, DUP-1031A, DUP-1046B, and DUP
1062A carried the expected inlA PMSCs (Table 3). In contrast,

ribotypes DUP-1025A and DUP-1052A contained isolates
with and without inlA PMSCs (Table 3). While PMSC muta
tions were more common among food isolates than among
human clinical isolates belonging to both ribotypes DUP
1025A and DUP-1052A, this association was only statistically
signiﬁcant (P � 0.05) for DUP-1052A isolates (Table 3). Ribo
types DUP-1025A and DUP-1052A contained isolates with
partial inlA sequences that showed 100% sequence identity
(within each ribotype), with the exception of their respective
PMSC mutations, suggesting a recent emergence of these inlA
allelic types.
Two recent studies (6, 24) provided initial evidence that L.
monocytogenes strains known to carry inlA PMSCs rarely cause
human listeriosis in the United States. We conducted queries
of the PathogenTracker database (www.pathogentracker.net),
which contains information for �5,000 L. monocytogenes
strains isolated predominantly in the United States and North
America from various sources (e.g., human and animal clinical
listeriosis cases, foods, healthy animals, and different environ
ments), to probe the distribution of the ribotypes carrying inlA
PMSCs on a larger scale. All L. monocytogenes ribotypes found
here to carry inlA PMSCs were extremely rarely or never detected
among animal isolates (Table 4), suggesting that a full-length InlA
protein may play a critical role in animal listeriosis. L. monocyto
genes ribotypes (DUP-1062A, DUP-16635A, DUP-1031A, and
DUP-1046B) exclusively associated with PMSC mutations and
one ribotype that was not exclusively associated with a PMSC
(DUP-1052A) were more commonly isolated from foods than
from human clinical cases (Table 4). A �2 test of independence
showed that ribotype DUP-1062A was signiﬁcantly more com
mon (P � 0.0001) among food isolates (n � 1,562) than among
human clinical isolates (n � 1,009). While a total of 52 human
clinical isolates grouped into one of the ribotypes found to be
associated with PMSCs, only 19 of these isolates actually car
ried the inlA PMSC mutations associated with the respective
ribotypes, as determined by sequencing of the 3� end of inlA.
Most of the human isolates carrying inlA PMSCs were ob

tained from blood (n � 16), while a single isolate each was
obtained from pleural ﬂuid and a skin graft site; no isolation
site data were available for one isolate. This distribution of
human isolates with inlA PMSC mutations is consistent with
results from a recent study in France, which showed that none
of 61 L. monocytogenes isolates from abortion cases carried a
truncated InlA protein (11). While these data suggest that InlA
may be critical for the ability of L. monocytogenes to cause
abortions, consistent with a study that found a role for inlA in
the invasion of trophoblasts (16), a recent study using a guinea
pig model did not support an important role for InlA in cross
ing the placenta in vivo (1). We thus conclude that L. mono
cytogenes isolates with PMSCs in inlA represent a considerable
subpopulation of L. monocytogenes isolates found in food
which rarely cause human disease and may have a reduced
ability to cause fetal infections. Further studies using L. mono
cytogenes isolates with inlA PMSCs will be necessary to evalu
ate the potential of these strains to cause abortions.
L. monocytogenes isolates with PMSCs show reduced inva
sion efﬁciencies. InlA has been shown to be sufﬁcient for the
invasion of human intestinal epithelial cells by L. monocyto
genes (21), and previous studies of L. monocytogenes isolates
from France carrying inlA PMSCs showed that these isolates
displayed reduced invasion with the Caco-2 human intestinal
epithelial cell line (27, 28). We paired L. monocytogenes iso
lates representing each unique inlA PMSC mutation identiﬁed
here with isolates with homologous partial inlA sequences (ex
cept for each nonsense mutation) to assess the ability of these
strains to invade Caco-2 cells (Table 2). While all DUP-1062A
isolates were shown to harbor an inlA PMSC mutation, partial
inlA sequences for DUP-1062A isolates were homologous to
the partial L. monocytogenes EGD-e inlA sequence (5), with
the exception of PMSC mutation type 3. We thus included
EGD-e, which groups into lineage II, as do all DUP-1062A iso
lates, as an initial nonisogenic control for ribotype DUP-1062A.
L. monocytogenes strains harboring inlA PMSCs showed signiﬁ
cantly (P � 0.0004) reduced invasion efﬁciencies in Caco-2 cells
compared to strains with full-length InlA (Fig. 4). Isogenic �inlA
and �inlAB null mutants showed an invasion capacity similar
to that of L. monocytogenes strains carrying inlA PMSCs, sup
porting the critical role of a cell wall-anchored InlA protein for
the invasion of human intestinal epithelial cells. The invasion
efﬁciency of the �inlB null mutant was lower than that of the
isogenic wild-type strain (10403S), but higher than that of the
corresponding isogenic �inlA mutant, consistent with previous
reports (14, 15).
To further characterize the effect of inlA PMSCs on inva
siveness without confounding other strain differences, we con
structed an isogenic L. monocytogenes 10403S mutant (FSL
W3-084; Table 2) with inlA PMSC mutation type 3. This iso
genic mutant was shown to produce a truncated and secreted
InlA protein (Fig. 2) and also showed reduced Caco-2 cell
invasion efﬁciency, similar to natural L. monocytogenes isolates
carrying PMSC types 1, 2, and 3. These data further support
the observation that L. monocytogenes strains with inlA PMSCs
are characterized by attenuated invasiveness and thus indicate
that SNPs in inlA may be suitable targets for the development
of rapid assays for the detection of virulence-attenuated
L. monocytogenes. However, based on the data presented here,
it is not possible to differentiate whether these inlA PMSC

FIG. 4. Caco-2 cell invasion efﬁciency of L. monocytogenes isolates
with inlA PMSC mutations. The isolates tested included L. monocyto
genes 10403S and an isogenic mutant with inlA PMSC mutation type 3
(FSL W3-084) as well as three pairs of wild-type strains with homol
ogous 3� inlA sequences, with and without the respective PMSC mu
tation types 1, 2, and 3; in addition, four control strains (10403S
isogenic �inlA, �inlB, and �inlA null mutants) were included (Table
2). The invasion efﬁciency of each L. monocytogenes strain was assayed
in triplicate in each independent experiment, and three independent
invasion experiments were performed for each strain. Bars represent
median invasion efﬁciencies (% of intracellular bacteria relative to
initial inoculum), and error bars indicate the minimum and maximum
invasion efﬁciencies observed for each strain or isolate. A nonpara
metric approximation of a t test showed that L. monocytogenes isolates
with inlA PMSC mutations have signiﬁcantly (P � 0.0004) reduced
invasion efﬁciencies in Caco-2 cells compared to isolates with an inlA
gene encoding full-length InlA.

mutations are fully responsible for the attenuated virulence
phenotype or whether these inlA PMSCs accumulated as a
result of the evolution of environmentally adapted ecotypes
with already reduced virulence, which did not require a fulllength InlA protein for ecological success. Further studies us
ing a carefully planned set of isogenic mutants (including a
DUP-1062A isolate with a replacement of PMSC mutation
type 3) and appropriate animal infection models (17) are nec
essary to more conclusively deﬁne the contribution of the inlA
PMSC mutations observed here to virulence attenuation, par
ticularly in light of recent data that showed that isogenic res
toration of another inlA PMSC failed to completely restore
virulence in a chicken embryo assay (27).
Truncated and secreted InlA is not associated with a healthy
L. monocytogenes fecal carriage state in ruminants. The occur
rence of at least nine distinct evolutionary events that gave rise
to ecologically successful inlA allelic variants carrying PMSC
mutations supports the hypothesis that the production of a
truncated and secreted InlA protein may provide a distinct
selective advantage in at least some speciﬁc niche. Olier et al.
(28) suggested that L. monocytogenes strains with truncated
InlA may be associated with a human fecal carriage state.
However, recent studies indicated that the prevalence of L.
monocytogenes in human stool samples from the general pop
ulation is often �1% (8, 9, 33). Since fecal L. monocytogenes
carriage in healthy farm ruminants appears to be quite com
mon (20, 25, 40), we hypothesized that a truncated and se
creted InlA may be associated with L. monocytogenes fecal

carriage in healthy ruminants. Screening by sequencing ap
proximately 1,600 bp at the 3� end of inlA of 58 L. monocyto
genes fecal isolates from healthy ruminants (set 2; Table 1),
representing ribotypes commonly isolated from ruminant fecal
samples, showed that none of these 58 isolates carried PMSCs
in the 3� 1,600 bp of inlA. These results are consistent with
Pathogen Tracker database query results, which showed a very
low prevalence of ribotypes associated with inlA PMSCs
among 1,297 animal isolates (Table 4). We thus conclude that
ruminants, including animals with clinical listeriosis and
asymptomatic fecal carriers, do not represent a reservoir for L.
monocytogenes strains with inlA PMSCs.
Conclusions. While several lines of evidence suggest that
L. monocytogenes strains differ in their ability to cause human
disease (6, 11), limited information on the speciﬁc genetic
characteristics responsible for these virulence differences is
available. In conjunction with a recent study of 150 food and
300 human isolates collected in France (11), our data strongly
suggest that a considerable proportion of L. monocytogenes
strains isolated from foods have a reduced ability to invade
human intestinal epithelial cells. Our data also support that
this attenuated invasiveness is linked to multiple distinct SNPs
in inlA which lead to the production of truncated and secreted
InlA molecules. Since L. monocytogenes strains with inlA
PMSCs have been isolated from some human cases, further
studies to determine whether human listeriosis cases caused by
isolates with PMSCs in inlA are associated with speciﬁc host
factors (e.g., extreme immunosuppression) are appropriate.
Nevertheless, the data presented here have important impli
cations for microbial risk assessments and regulations targeting
L. monocytogenes by identifying genetically well-deﬁned and
biologically meaningful L. monocytogenes subpopulations that
appear to have reduced human virulence. In addition to the
signiﬁcance of our ﬁndings for food safety and public health,
our data contribute to our understanding of the ecology and
evolution of L. monocytogenes. In particular, future efforts to
elucidate the selective advantages associated with the produc
tion of a truncated and secreted InlA protein may provide a
better understanding of the function of L. monocytogenes in
ternalins in different hosts and nonhost environments.
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